Drugs group AstraZeneca sees annual profit almost double

LONDON: British drugs group AstraZeneca said on Thursday that net profit almost doubled to $6.0 billion last year, with a strong cancer division helping offset a huge decline in sales of Covid treatments.

“As AstraZeneca celebrates its 25th anniversary, we are pleased to report another year of strong financial performance and scientific progress, with double-digit earnings growth,” Chief Executive Pascal Soriot said in the results statement.